UBS raises Marathon Petroleum stock price target to $220 on Russian export cuts

Marathon Petroleum (MPC) received a price target increase from UBS to $220.00 from $203.00, maintaining a Buy rating, driven by anticipated global product tightness. This tightness stems from reduced Russian refined product exports, which declined approximately 10% in September due to Ukrainian drone attacks, a situation expected to benefit U.S. refiners. The positive outlook is further supported by MPC's strong Q2 2025 financial results, which significantly exceeded EPS and revenue forecasts, leading other analysts like TD Cowen to also raise their price targets.

Analysis

Marathon Petroleum's (MPC) investment thesis has been significantly strengthened by a combination of favorable geopolitical events and strong company-specific performance. UBS has raised its price target to $220 from $203, maintaining a Buy rating, citing global petroleum product tightness. This market condition is a direct consequence of reduced Russian refining output, reportedly impacted by Ukrainian drone attacks, which caused a ~10% month-over-month decline in Russian product exports in September. The drop was particularly acute in diesel and gasoil, with exports falling 18% to 676,000 barrels per day. This supply-side constraint is expected to directly benefit U.S. refiners like MPC. The bullish outlook is further substantiated by MPC's robust second-quarter 2025 results, where it reported an EPS of $3.96 against a forecast of $3.11 and revenue of $34.1 billion versus a $33.04 billion estimate. This outperformance has led to upward revisions in earnings estimates, with UBS lifting its 2025 EPS forecast for MPC to $8.14. Despite the stock's impressive 43% year-to-date return and trading near its 52-week high, the confluence of these factors has prompted bullish analyst sentiment, with TD Cowen also increasing its price target to $195.

Key Decisions for Investors

• Given the strong earnings beat and clear geopolitical tailwinds from constrained Russian supply, investors could view the stock as having continued upside potential, validating the bullish stance of analysts from UBS and TD Cowen.
• Investors should closely monitor trends in global crack spreads and Russian refined product export volumes, as these are the primary catalysts underpinning the current positive thesis and any reversal could signal a change in outlook.
• With the stock trading near its 52-week high after a 43% YTD rally, investors with existing positions may consider the new $220 UBS price target as a potential near-term objective, while new capital should be deployed with consideration for the elevated valuation.